Primary information |
---|
sequence ID | Seq_2676 |
Peptide sequence | GGGGGGLGSGGSIRSS |
CancerPDF_ID | CancerPDF_ID8866, CancerPDF_ID11482, |
PMID | 24694173,26992070 |
Protein Name | "Keratin, type I cytoskeletal 9","Keratin, type I cytoskeletal 9" |
UniprotKB Entry Name | K1C9_HUMAN,K1C9_HUMAN |
Fluid | Ascites fluid,Serum |
M/Z | NA,1261.6011 |
Charge | 1,NA |
Mass (in Da) | NA,1262.611742 |
fdr | NA,NA |
Profiling Technique | LTQ-Orbitrap XL,LC-MS |
Peptide Identification technique | X tandem for peptide identification,LC-MS/MS |
Quantification Technique | NA,NA |
Labelled/Label Free | Label Free,Label Free |
FDR | NA,FDR 1 % |
CancerPDF_ID | CancerPDF_ID8866, CancerPDF_ID11482, |
p-Value | NA,NA |
Software | "X tandem for peptide identification,Scaffold 2 software for any modification analysis",SEQUEST and Maxquant |
Length | 16,16 |
Cancer Type | Ovarian cancer,Melanoma |
Database | IPI00019359,SwissProt Database |
Modification | NA,NA |
Number of Patients | 3 ovarian cancer patient and 3 non cancerous control,8 cancer samples and 4 healthy samples |
Regulation | Uniquely expressed in ovarian cancer patient,"Present in 7 cancer samples out of 8 cancer samples. ,Present in 3 healthy samples out of 4 healthy samples." |
Validation | NA,na |
Sensitivity | NA,NA |
Specificity | NA,NA |
Accuracy | NA,NA |
Peptide Atlas | PeptideAtlas |
IEDB | 239712
239713
240331
240394
240525
240526
|